Five years ago I joined the Astra Zeneca clinical trial of Olaparib with Zytiga, through my oncologist at Fox Chase in Philadelphia. Earlier this year A-Z ended the trial and applied for FDA approval of the combo, it does seem to help some of us. I learned that I had been taking the placebo, not the trial med. No problem, that's the nature of a trial.
Now however A-Z won't answer whether they will continue to supply Zytiga, and the trial coordinator believes they will not, they probably will stop it sometime during 2024. My current Medicare Part D drug plan won't supply it either, so I need to change to a more expensive drug plan during this annual change window, which ends Dec 7, just to cover myself in the event A-Z does in fact stop supplying.
I don't have a beef with most of this, except for A-Z's refusal to give a timely answer during this Part D enrollment period. That feels like a slap in the face, an above-the-fray unwillingness to recognize the patient realities of our tortuous US medical insurance system.